- Series B capital raising round is open to sophisticated, professional and overseas investors
- Funds from this round will be used to continue studies
- The investment round is scheduled to close the earlier of 1 March 2018
4Dx is pleased to announce to our extended network that our Series B capital raising round is open to sophisticated, professional and overseas investors. This will be followed by a retail fundraising round component open to the general investment community in the coming weeks.
For those interested in an updated investment snapshot, you may download our 4Dx Company Information Deck: Series B Capital Raising October 2017 on our 4Dx Investor webpage.
For those sophisticated, professional and overseas investors wishing to register your interest, please do so via the Register Your Interest webform on our 4Dx Investor webpage. You will be contacted with further information on how to access the Information Memorandum and other investment documentation contained in our private Series B Data Room.
For those interested in participating in our retail fundraising round, you will receive notification of how to participate in coming weeks.
Funds from this round will be used to continue studies to validate the accuracy and repeatability of software product, make FDA submissions for our core software, expand our US office, with a focus on building market opportunity in that geography, and provide working capital to meet ongoing operational costs.
The investment round is scheduled to close the earlier of 1 March 2018, or once our A$4,995,000 target is achieved.